Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

Rengaswamy Sankaranarayanan(Centre International de Recherche sur le Cancer), Priya R. Prabhu(Rajiv Gandhi Centre for Biotechnology), Michael Pawlita(German Cancer Research Center), Tarik Gheit(Centre International de Recherche sur le Cancer), Neerja Bhatla(All India Institute of Medical Sciences), Richard Muwonge(Centre International de Recherche sur le Cancer), Bhagwan M. Nene(Tata Memorial Hospital), Pulikottil Okuru Esmy, Smita Joshi(Jehangir Hospital), Usha Rani Poli(MNJ Institute Of Oncology and Regional Cancer Centre), Parimal Jivarajani(HCG Cancer Centre), Yogesh Verma(Sikkim Manipal University), Eric Zomawia(Aizawl Adventist Hospital), Maqsood Siddiqi(Cancer Foundation of India), Surendra S. Shastri(Tata Memorial Hospital), Kasturi Jayant(Tata Memorial Hospital), Sylla G. Malvi(Nargis Dutt Memorial Cancer Hospital), Eric Lucas(Centre International de Recherche sur le Cancer), Angelika Michel(German Cancer Research Center), Julia Butt(Heidelberg University), Janki Mohan Babu Vijayamma(Rajiv Gandhi Centre for Biotechnology), Subha Sankaran(Rajiv Gandhi Centre for Biotechnology), Thiraviam Pillai Rameshwari Ammal Kannan(Rajiv Gandhi Centre for Biotechnology), Rintu Varghese(Rajiv Gandhi Centre for Biotechnology), Uma Divate(Jehangir Clinical development Centre), Shila Thomas, Geeta Joshi(Gujarat Cancer & Research Institute), Martina Willhauck‐Fleckenstein(Heidelberg University), Tim Waterboer(German Cancer Research Center), Martin Müller(Heidelberg University), Peter Sehr(Heidelberg University), Sanjay Hingmire(Tata Memorial Hospital), Alka Kriplani(All India Institute of Medical Sciences), Gauravi Mishra(Tata Memorial Hospital), Sharmila Pimple(Tata Memorial Hospital), Radhika Jadhav(Jehangir Clinical development Centre), Catherine Sauvaget(Centre International de Recherche sur le Cancer), Massimo Tommasino(Centre International de Recherche sur le Cancer), Madhavan Radhakrishna Pillai(Rajiv Gandhi Centre for Biotechnology)
The Lancet Oncology
December 1, 2015
Cited by 247Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis